Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2012

Influence of primary care physician availability and
socioeconomic deprivation on breast cancer from 1988 to 2008:
A spatio-temporal analysis
Lung-Chang Chien
Washington University School of Medicine in St. Louis

Anjali D. Deshpande
Washington University School of Medicine in St. Louis

Donna B. Jeffe
Washington University School of Medicine in St. Louis

Mario Schootman
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Chien, Lung-Chang; Deshpande, Anjali D.; Jeffe, Donna B.; and Schootman, Mario, ,"Influence of primary
care physician availability and socioeconomic deprivation on breast cancer from 1988 to 2008: A spatiotemporal analysis." PLoS One. 7,4. 1-11. (2012).
https://digitalcommons.wustl.edu/open_access_pubs/1008

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Influence of Primary Care Physician Availability and
Socioeconomic Deprivation on Breast Cancer from 1988
to 2008: A Spatio-Temporal Analysis
Lung-Chang Chien*, Anjali D. Deshpande, Donna B. Jeffe, Mario Schootman
Division of Health Behavior Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America

Abstract
Background: Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among
women in the United States. It is unclear how county-level primary care physician (PCP) availability and socioeconomic
deprivation affect the spatial and temporal variation of breast cancer incidence and mortality.
Methods: We used the 1988–2008 public-use county-based data from nine Surveillance, Epidemiology, and End Results
(SEER) programs to analyze the temporal and spatial disparity of PCP availability and socioeconomic deprivation on earlystage incidence, advanced-stage incidence and breast cancer mortality. The spatio-temporal analysis was implemented by a
novel structural additive modeling approach.
Results: Greater PCP availability was significantly associated with higher early-stage incidence, advanced-stage incidence
and mortality during the entire study period while socioeconomic deprivation was significantly negatively associated with
early-stage incidence, advanced-stage incidence, and mortality up to 1992. However, the observed influence of PCP
availability and socioeconomic deprivation varied by county.
Conclusions: We showed important associations of PCP availability and socioeconomic deprivation with the three breast
cancer indicators. However, the effect of these associations varied over time and across counties. The association of PCP
availability and socioeconomic deprivation was stronger in selected counties.
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strong predictor of its use [11–16]. Previous studies showed that
women living in areas with fewer PCPs may be less likely to be
screened and have higher mortality rates [17,18]. Also, countylevel socioeconomic deprivation may be related to breast cancer
incidence and mortality because areas with greater deprivation
may have fewer primary care physicians, limited mammography
facilities, and fewer resources for mammography use [19].
Therefore, it becomes important to determine if PCP availability
and socioeconomic deprivation can explain observed longitudinal
trends and geographic patterns of breast cancer incidence and
mortality.
The purpose of this study was to investigate the spatial and
temporal variation of breast cancer incidence and mortality due to
county-level PCP availability and socioeconomic deprivation using
the 1998–2008 county-based data from 200 counties in nine
Surveillance, Epidemiology, and End Result (SEER) registries.
Specifically, two questions were addressed: (a) whether change in
PCP availability and socioeconomic deprivation over time is
associated with an ascending or descending trend in breast cancer
incidence and mortality from 1988 to 2008, and (b) whether the
effect of county-level PCP availability and socioeconomic

Introduction
Breast cancer is the most commonly diagnosed cancer and the
second leading cause of cancer death among women in the United
States. Breast cancer indicators, such as incidence and mortality,
vary over time and across geographic areas in the US [1]. Most of
the increase in breast cancer incidence in the 1980’s has been
attributed to increase in mammography use. A subsequent decline
in incidence likely reflected the saturation of screening in the
1990’s [2] and a reduction in postmenopausal hormone
replacement therapy use in the early 2000s [3]. Breast cancer
mortality in the U.S. significantly declined 1.9% per year from
1998 to 2006 due to early detection and increased adjuvant
therapy use [4]. Temporal trends in breast cancer mortality also
varied by state [5]. Studies also have documented local areas
where breast cancer risk was elevated [6–10].
Two potential explanations for the temporal change and
geographic disparities in breast cancer incidence and mortality
are primary care physician (PCP) availability and socioeconomic
deprivation at the county level. PCP availability is likely to be an
important influence on breast cancer indicators as there is clear
evidence that physician recommendation for mammography is a
PLoS ONE | www.plosone.org
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physicians reported their primary specialty area as general or
family practice or reported most of their clinical hours in the
practice of obstetrics/gynecology or internal medicine [20].
The socioeconomic deprivation index was constructed from a
factor analysis of 46 county-level Census variables from the 1990
and 2000 U.S. Census [21]. We selected the 46 variables for
analysis from the 2000 census that were identified from four key
studies [22–25] and our own conceptualization of socioeconomic
deprivation. Eight different domains were considered: education,
employment, occupation, housing, poverty, racial/ethnic composition, residential stability, and other. We excluded 23 census
variables that measured the inverse of a census variable already
included or were very similar constructs. One 6-item common
factor emerged: percentage without high school education,
percentage unemployed, percentage living in crowded housing
(.1 person/room), percentage without a car, percentage without a
telephone, and percentage of population below federal poverty
rate. Cronbach’s alpha was 0.93, and 73.6% of the overall
variance was explained by this factor. Because our study data also
spanned the 1990 census, we calculated the correlation between
the 2000 county index score and the 1990 county index score,
computing each index score using the same six census variables.
The correlation was 0.881, suggesting that counties with high
levels of socioeconomic deprivation in 1990 also had high levels of
socioeconomic deprivation in 2000. The correlation between the
county-level PCP availability index and the socioeconomic
deprivation index was 0.03 (p = 0.14).

deprivation on breast cancer incidence and mortality is more
pronounced in some counties.

Methods
Data source and breast cancer indicators
The 1988–2008 county-based data from nine population-based
SEER programs were used to derive three breast cancer indicators
(early-stage incidence, advanced-stage incidence and mortality),
year of diagnosis and county information. The nine SEER areas,
including 5 states (Connecticut, Hawaii, Iowa, New Mexico, and
Utah) and 4 cities (Atlanta, Detroit, San Francisco, and Seattle),
covered 200 counties with about 9% of the United States
population. Women age 40 and older were included in the study
if they were diagnosed with a first primary breast cancer (ICD-9
codes: 174, 217, 233) and/or if they died from breast cancer (ICD10 codes: C50, D05, D24) between 1988 and 2008. Subsequent
cancers among women with first primary breast cancer were not
included. The study period began in 1988, the first year for which
detailed data about lymph node involvement was available in
order to use the American Joint Commission on Cancer tumornode-metastasis (TNM) staging system. Early-stage breast cancer
consisted of in situ breast cancer and invasive breast cancers that
were ,2 cm at the time of diagnosis. Advanced-stage breast
cancer was defined as TNM stage II and stage III tumors, which
include tumors .2 cm and/or have spread to nearby lymph
nodes, and TNM stage IV cancers which have spread beyond the
breast and lymph nodes to other parts of the body. Breast cancer
mortality was determined by death certificates. Women with
breast cancer who died from other causes were not included in the
breast cancer mortality rate. Because the data we used was a
public-use dataset, written consent given by the patients for their
diagnosis with breast cancer and personal information was not
needed. County-level boundary data were obtained from the U.S.
Census Bureau.
This study measured the effects of two county-level determinants including a PCP availability index and a socioeconomic
deprivation index. PCP availability was defined as the ratio of the
number of PCP per 100,000 women age 40 and older in each
county, and data were obtained from the Area Resource File for
each of the 200 counties in each year during 1988–2008. Included

Statistical methodology: structural additive regression
model
We examined the spatial distributions in breast cancer incidence
and mortality rates and possible nonlinear effects using structural
additive regression (STAR) models in order to account for
temporal autoregressive correlation and spatial autocorrelation
among 200 counties during 1988–2008 [26]. Based on these
models, we established a varying-coefficient model (VCM) to
investigate the influence of the two determinants on the breast
cancer indicators over time and a separate random-effects model
(REM) to examine the effect of these determinants on the breast
cancer indicators in each of the 200 counties. Each of the two
models was fitted for the three breast cancer indicators separately.

Table 1. Average frequencies and crude rates for three breast cancer indicators in nine SEER areas, 1988–2008.
# of
Area

counties

Early-stage incidence
Frequency

Rate

{

Advanced-stage incidence

Mortality

Frequency

Frequency

Rate

Rate

San Francisco

5

31,003

164.3

23,054

122.1

9,032

47.9

Connecticut

8

30,138

176.0

20,912

122.1

9,357

54.7

Atlanta

5

16,345

142.9

12,975

113.4

4,787

41.9

Hawaii

5

9,231

166.5

5,920

106.8

1,841

33.2

Iowa

99

22,101

153.7

17,182

119.5

7,777

54.1

Detroit

3

29,867

155.9

24,295

126.8

11,144

58.2

New Mexico

33

9,697

123.5

8,190

104.3

3,324

42.4

Utah

29

9,610

128.3

7,964

106.3

2,963

39.5

Seattle

13

31,582

176.4

21,846

122.0

7,458

41.7

Total

200

189,574

155.9

142,338

119.5

57,683

42.4

{
Median of county-year-age-race specific standardized crude rate (per 100,000 women).
doi:10.1371/journal.pone.0035737.t001
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Table 2. Model diagnostics and variance components of structured and unstructured spatial function in three breast cancer
indicators.

Early-stage incidence
VCM

REM

Advanced-stage incidence

Mortality

VCM

VCM

REM

REM

D(h)

4203.80

4201.45

4200.53

4196.55

4201.14

4200.83

pd

216.34

222.74

210.89

213.09

211.87

212.61

DIC

4420.14

4424.19

4411.42

4409.64

4413.01

4413.44

s2s

2.26

3.96

3.18

1.62

0.85

2.16

(0.76, 4.62)

(1.92, 6.29)

(1.25, 5.64)

(0.43, 3.86)

(0.22, 1.84)

(0.97, 3.94)

0.56

0.42

0.43

0.64

0.78

0.52

(0.02, 1.02)

(0.003, 1.03)

(0.004, 0.94)

(0.09, 1.09)

(0.46, 1.11)

(0.14, 0.96)

0.80

0.90

0.88

0.72

0.52

0.81

(95% CI)

s2u (95% CI)
psD(szu)

Abbreviation: VCM = varying-coefficient model; REM = random-effects model, D(h) = posterior mean of the deviance; pd = effect number of parameters; s2s = structured
spatial variance; s2u = unstructured spatial variance; psD(szu) = proportion of the structured spatial variance in total spatial variance.
doi:10.1371/journal.pone.0035737.t002

Assume pct ~( pEct pA
pM
ct
ct ) is the county-year-age-race adjusted rate for each breast cancer indicator using the 2000 U.S.
standard population, respectively, where c M(1, 2, …, 200) denotes
the index of county, t M(1, 2, …, 21) denotes the year from 1988 to
2008, E denotes early-stage incidence, A denotes advanced-stage
incidence, and M denotes mortality. To implement the timevarying coefficient along with the adjustment of temporal
autoregressive and spatial correlation, a VCM can be defined by:
log(pct )~azb1 |g1 (t)|PCPct zb2 |g2 (t)|SEDct
u
s
zf (t)zfspat
(c)zfspat
(c)

ð1Þ

where a is an intercept explained as an overall log relative risk for
all counties, and g(t) is a second order random walk smoothness
prior along with linear predictors. The parameters b1 and b2
denote temporal fixed effect vectors with dimension 1621 for the
PCP availability variable (PCPct ) and the socioeconomic deprivation variable (SEDct ), respectively. The function f (t) is a time
smoother fitted by a penalized spline based on Bayesian P-spline
priors [27]. Its functionality is mainly for controlling autoregressive
correlations among our longitudinal data. In eq.(1), we used a
second order random walk prior to ensure flexibility of the
Gaussian errors and diffuse priors for the initial values of the time
smoother.
To account for the heterogeneity due to spatial dependence, the
spatial effect was decomposed into two terms: an unstructured
u
(c) fitted by an exchangeable normal prior
spatial term fspat
s
(c) fitted by Markov
N(0,s2u ) and a structured spatial function fspat
random fields (MRF). The MRF assumed a conditional
autoregressive
prior [28] defined as cDc0 ,c=c0 ,s2 *N
P
s
(c0 )=Nc ,s2c =Nc ). The term Nc is the number of
( c0 [vc fspat
adjacent counties around county c, and c9 Mvc means that county
c9 is one of the neighboring counties vc of county c. The two
spatial components include a spatially correlated part (structured
term) and a spatially uncorrelated part (unstructured term) to
distinguish between two types of spatially unobserved covariates,
namely, those covariates that examine a strong geographic
heterogeneity and those covariates that are identified locally
[28,29]. Two unknown variance components s2u and s2s were
assigned an inverse Gamma hyper-prior with known hyperparameters (a, b) = (0.001, 0.001). The intercept was assumed to
have a flat prior [30]. This study mainly used the structured spatial
PLoS ONE | www.plosone.org

Figure 1. Time-varying estimated coefficient in the VCM for
early-stage breast cancer incidence. (A) PCP availability. (B)
Socioeconomic deprivation. The dash line is 95% credible interval.
doi:10.1371/journal.pone.0035737.g001
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Figure 2. Maps for structured spatial function in the VCM and REM for early-stage breast cancer incidence. (Left) Estimated structured
spatial effect, where the range was categorized by 5-quantiles. (Right) 80% posterior probabilities, where black colour means significantly positive
spatial effect, grey colour means significantly negative spatial effect, and tan colour means non-significantly spatial effect.
doi:10.1371/journal.pone.0035737.g002

blocks of parameters conditional on the rest of parameters and the
data [29]. More details can be found in Brezger’s and Lang’s
methodological paper [31]. Briefly, for each model, 22,000
iterations were carried out, with the first 2,000 samples used as
burn in. We stored every 20th sample from the remaining 20,000
samples, giving a final sample of 1,000 for estimating the model
parameters. The significance of the estimates for PCPct and
SEDct was determined by their 95% CIs. Model diagnostics used
the deviance information criterion (DIC) is based on the sum of
the posterior mean of the deviance and the effective number of
parameters [32]. Maps of the county-level structured spatial
function and county-level random effects in VCM and REM
displayed the geographic distribution of breast cancer incidence
and mortality. The data analysis was implemented by the BayesX
2.01 software package [33].

effect to show the impact of county location on breast cancer
incidence and mortality. The statistical significance of the
structured spatial effect relative to the background rate was
determined by its 80% posterior probability, with results classified
as a statistically significant positive spatial effect, a statistically
significant negative spatial effect, or a statistically non-significant
spatial effect.
The REM is the same as a generalized linear mixed model with
only random effects, but the functionality of the structural additive
models makes the spatial heterogeneity estimable along with the
estimation of the random effects. It was defined as:
u
s
log(pct )~azb1c |PCPct zb2c |SEDct zf (t)zfspat
(c)zfspat
(c) ð2Þ

where two random effects, b1c and b2c , can be explained by the log
relative risk for each increment of PCPct and SEDct in a specific
county c. The remaining assumptions of unknown parameters and
functions are identical to those used in the VCM. To evaluate the
change in the breast cancer indicators attributed to PCP
availability and to socioeconomic deprivation, a REM without
PCPct , a REM without SEDct and a REM without both PCPct
and SEDct were fitted to compare the results generated from
eq.(2), respectively.
All models were fitted using a fully Bayesian influence approach
using Markov Chain Monte Carlo techniques, which is carried out
by randomly drawing from the full conditional distributions of

PLoS ONE | www.plosone.org

Results
Demographics
From 1988 to 2008, 189,574 women were diagnosed with earlystage breast cancers, 142,338 women were diagnosed with
advanced-stage breast cancer, and 57,683 women died of breast
cancer (Table 1). The crude rates per 100,000 population of earlystage incidence ranged from 123.5 in New Mexico to 176.4 in
Seattle. New Mexico also had the lowest crude rate of advancedstage incidence with 104.3 per 100,000 population and Detroit
had the highest crude rate of advanced-stage incidence and
4
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Figure 3. Maps for estimated county-level random effects in
the REM for early-stage breast cancer incidence. (A) PCP
availability. (B) Socioeconomic deprivation.
doi:10.1371/journal.pone.0035737.g003

mortality with 126.8 and 58.2 per 100,000 population, respectively. The lowest crude mortality rate was found in Hawaii with
33.2 per 100,000 population.
Figure 4. Time-varying estimated coefficient in the VCM for
advanced-stage breast cancer incidence. (A) PCP availability. (B)
Socioeconomic deprivation. The dash line is 95% credible interval.
doi:10.1371/journal.pone.0035737.g004

Model diagnostics and spatial variances
Table 2 shows that the two types of models had similar DIC
values for the three breast cancer indicators, suggesting that both
models fit equally well. Variance components show that for the
REM the structured spatial component (s2s ) had a larger variance
than unstructured spatial component (s2u ) for each breast cancer
indicator, suggesting that the spatial heterogeneity played a more
dominant role than the random spatial intercepts. The structured
spatial variance also was larger than the unstructured spatial
variance in the VCM for early-stage and advanced-stage
incidence.

logRR gradually increased from 20.25 (95% CI = 20.41, 20.10)
in 1988 to 20.13 (95% CI = 20.26, 20.001) in 1990, see
Figure 1(B).
Figure 2 displays the structured spatial variability in early-stage
incidence across 200 counties for the VCM and REM approaches.
Significantly positive spatial effects, determined by 80% posterior
probability of logRR.0, was present in 41 counties in the VCM
and 48 counties in the REM, mostly in metropolitan SEER areas.
This finding suggests that at least 20% of counties had significantly
elevated early-stage incidence due to their locations after
controlling for county-specific PCP availability and socioeconomic
deprivation in either model. Figures 3(A) and 3(B) display the
county-specific associations of PCP availability and socioeconomic
deprivation with early-stage incidence estimated by the REM for
all 200 counties. The association of both determinants with earlystage incidence varied by county, where the variances of random
effects were 0.13 (95% CI = 0.002, 0.94) for PCP availability and
0.18 (95% CI = 0.06, 0.35) for socioeconomic deprivation.
The county-level influence of PCP availability and socioeconomic deprivation varied across counties in different SEER areas

Early-stage breast cancer incidence
The association (estimated as the log relative risk [logRR]) of
PCP availability with early-stage breast cancer incidence declined
over time from 3.72 (95% CI = 2.59, 4.81) in 1988 to 2.45 (95%
CI = 1.63, 3.22) in 2008, see Figure 1(A). Thus, the lower bound of
the 95% CI for each logRR of PCP availability was above zero,
suggesting that during this study period higher PCP availability
was associated with higher early-stage breast cancer incidence.
However, the magnitude of this association declined 34.1%
([3.72–2.45]/3.72) during the 21 year study period. Significant
associations between socioeconomic deprivation and early-stage
incidence were observed only from 1988 to 1990, where the
PLoS ONE | www.plosone.org
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6
33
29
13

New Mexico

Utah

Seattle

0.80–3.96

0.85–22.60

0.85–18.03

2.06–3.11

0.82–8.63

0.88–11.66

1.05–3.98

0.71–3.54

1.66–3.07

Range

PCP availability

Mortality

0.95–1.46

0.95–3.29

0.91–2.14

1.03–1.37

0.92–1.58

0.98–2.50

0.96–1.70

0.96–1.48

1.13–1.54

Range

PCP availability

Advanced-stage incidence

0.99–1.05

0.97–1.17

0.93–1.09

1.00–1.03

0.98–1.05

0.99–1.15

0.99–1.08

0.98–1.06

1.01–1.08

Range

PCP availability

{
N = number of counties; PCP = primary care physicians.
doi:10.1371/journal.pone.0035737.t003

99
3

5

Hawaii

Detroit

5

Atlanta

Iowa

8

13

Seattle

Connecticut

29

Utah

N

33

New Mexico

5

3

Detroit

San Francisco

99

Iowa

Area

5

13

Seattle

Hawaii

29

Utah

5

33

New Mexico

8

3

Detroit

Atlanta

99

Iowa

Connecticut

5

Hawaii

N

5

Atlanta

5

8

Connecticut

San Francisco

5

San Francisco

Area

N

Area

{

Early-stage incidence

1.65

2.25

1.61

2.43

1.14

3.46

2.59

1.63

2.24

Mean

1.15

1.15

1.04

1.24

1.02

1.35

1.27

1.10

1.24

Mean

1.01

1.01

1.00

1.02

1.00

1.04

1.02

1.02

1.03

Mean

0.8257

18.3064

8.7430

0.3451

0.6398

21.2464

1.1458

1.1179

0.4232

Variance

0.0274

0.2000

0.0407

0.0337

0.0060

0.4201

0.0716

0.0323

0.0309

Variance

0.0004

0.0012

0.0005

0.0003

0.0002

0.0042

0.0013

0.0006

0.0008

Variance

Range

0.93–1.23

0.79–1.25

0.77–1.22

0.96–1.05

0.77–1.22

0.69–1.13

1.02–1.11

0.96–1.06

0.98–1.00

Range

Socioeconomic deprivation

0.95–1.06

0.90–1.08

0.84–1.17

0.98–1.04

0.92–1.11

0.90–1.07

1.01–1.07

0.98–1.03

0.99–1.01

1.01

0.99

0.98

1.00

1.01

1.01

1.06

1.01

0.98

Mean

1.00

1.00

0.99

1.01

1.00

1.02

1.03

1.00

1.00

Mean

1.01

1.01

0.96

1.02

1.01

1.14

1.08

1.02

0.96

Mean

Socioeconomic deprivation

0.93–1.20

0.71–1.81

0.48–2.62

0.92–1.13

0.80–1.27

0.82–1.35

0.95–1.23

0.95–1.13

0.90–1.00

Range

Socioeconomic deprivation

0.0060

0.0094

0.0126

0.0024

0.0037

0.0314

0.0015

0.0012

0.0001

Variance

0.0007

0.0016

0.0046

0.0007

0.0007

0.0046

0.0005

0.0004

0.0002

Variance

0.0044

0.0435

0.1191

0.0110

0.0083

0.0380

0.0104

0.0050

0.0014

Variance

Table 3. Geographic disparity of county-specific relative risk of PCP availability and socioeconomic deprivation on three breast cancer indicators by SEER areas, presented by RR.
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Figure 5. Maps for structured spatial function in the VCM and REM for advanced-stage breast cancer incidence. (Left) Estimated
structured spatial effect, where the range was categorized by 5-quantiles. (Right) 80% posterior probabilities, where black colour means significantly
positive spatial effect, grey colour means significantly negative spatial effect, and tan colour means non-significantly spatial effect.
doi:10.1371/journal.pone.0035737.g005

Figure 5 illustrates that the structured spatial effect in advancedstage breast cancer incidence varied across the counties based on
the VCM and REM. Among 200 counties, 37 counties in the
VCM and 45 counties in the REM had significantly positive
spatial estimates. Most of these counties were located in
metropolitan SEER areas. Figure 6 indicates that the countyspecific logRR varied across counties, where the variances of
random effects were 1.22 (95% CI = 0.002, 6.81) for PCP
availability and 0.04 (95% CI = 0.001, 0.14) for socioeconomic
deprivation.
Table 3 shows that the variance of the association of PCP
availability with advanced-stage breast cancer incidence across the
counties for each of the SEER areas was generally larger than the
variance of the association of socioeconomic deprivation with
advanced-stage breast cancer incidence. Hawaii and Utah had the
largest variances, indicating that the association between PCP
availability and advanced-stage incidence varied the most across
counties in these two areas.

(Table 3). Larger variances suggest large geographic disparity for
the county-specific association between each of the two risk factors
and early-stage breast cancer incidence. The association between
PCP availability and early-stage breast cancer incidence varied the
most across the five counties in Hawaii (variance = 0.0042) and
least across the 99 counties in Iowa (variance = 0.0002). Across all
counties, the RR ranged from a low of 0.93 to a high of 1.17. In
contrast, the association between socioeconomic deprivation and
early-stage breast cancer incidence varied the most across the 33
counties in New Mexico (variance = 0.1191) and the least across
the 5 counties in the San Francisco area (variance = 0.0014). In
one New Mexico county, increasing socioeconomic deprivation
was strongly associated with a lower incidence of early-stage breast
cancer (RR = 0.48) while in another New Mexico county
increasing socioeconomic deprivation increased the early-stage
breast cancer incidence (RR = 2.62).

Advanced-stage breast cancer incidence
Figure 4(A) shows a strong association between PCP availability
and advanced-stage incidence over time since the 95% CI of the
time-varying logRR excluded zero in each year. The association
declined slightly from 1988 to 2008. Figure 4(B) shows that the
socioeconomic deprivation and advanced-stage incidence were
only statistically associated in 1988 (logRR = 20.20; 95%
CI = 20.35, 20.06), but not after 1988.

PLoS ONE | www.plosone.org

Breast cancer mortality
As shown in Figure 7(A), PCP availability had a consistently
positive and significant association with breast cancer mortality
from 1988 to 2008. The logRR of PCP availability declined from
4.35 (95% CI = 3.08, 5.58) in 1988 to 3.08 (95% CI = 2.16, 3.94)
in 2008. As shown in Figure 7(B), only during 1988–1992 was
socioeconomic deprivation significantly associated with breast
7

April 2012 | Volume 7 | Issue 4 | e35737

Spatio-Temporal Breast Cancer Analysis

Figure 6. Maps for estimated county-level random effects in
the REM for advanced-stage breast cancer incidence. (A) PCP
availability. (B) Socioeconomic deprivation.
doi:10.1371/journal.pone.0035737.g006

cancer mortality, whereby counties with higher socioeconomic
deprivation had lower logRR of breast cancer mortality.
Figure 8 shows the large structured geographic variability in
breast cancer mortality across the 200 SEER counties in the VCM
and REM, especially in metropolitan SEER areas. Of the 2000
SEER counties, 34 counties in the VCM (17.0%) and 39 counties
in the REM (19.5%) had at least an 80% posterior probability of
increased breast cancer mortality (logRR.0). Figure 9 shows that
county-specific effects of PCP availability and socioeconomic
deprivation varied across counties based on the REM, where the
estimated variances of the random effects were 5.76 (95%
CI = 0.01, 22.00) for PCP availability and 0.10 (95% CI = 0.004,
0.32) for socioeconomic deprivation.
The county-specific association of PCP availability with the
mortality rate showed greater variability than the county-specific
association of socioeconomic deprivation with the mortality rate in
each SEER area (Table 3). The largest variance of the association
between PCP availability and the mortality rate was in Hawaii,
although the variability in this association was also large across
counties in New Mexico and Utah. For many counties, increasing
PCP availability was associated with an increasing mortality rate.

Figure 7. Time-varying estimated coefficient in the VCM for
breast cancer mortality. (A) PCP availability. (B) Socioeconomic
deprivation. The dash line is 95% credible interval.
doi:10.1371/journal.pone.0035737.g007

level SEER data from 1988–2008. Our study showed two main
findings. First, increasing PCP availability was significantly
associated with increasing early-stage breast cancer incidence,
advanced-stage incidence, and mortality over the entire study
period, but socioeconomic deprivation was only significantly
associated with the three breast cancer indicators during the early
years of the study period. Second, large geographic disparities
across the SEER counties were observed in the associations of PCP
availability and socioeconomic deprivation with each of the three
breast cancer indicators.
As described, PCP availability increased the likelihood of earlystage breast cancer incidence, but the association declined over
time. A likely explanation is the increased prevalence of
mammography service and use since the late 1980s. This result
is consistent with a previous study of the benefit of screening
mammography on early-stage breast cancer diagnoses, which
found overall age-adjusted breast cancer incidence rates increased
25% from the early 1980s to 1993, and then dropped by 18% in
2004 [34]. A positive relationship between PCP availability and

Discussion
The purpose of this study was to examine the association and
geographic disparity of PCP availability and socioeconomic
deprivation over time with three breast cancer indicators using
spatio-temporal analysis with structural additive models of county-

PLoS ONE | www.plosone.org
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Figure 8. Maps for structured spatial function in the VCM and REM for breast cancer mortality. (Left) Estimated structured spatial effect,
where the range was categorized by 5-quantiles. (Right) 80% posterior probabilities, where black colour means significantly positive spatial effect,
grey colour means significantly negative spatial effect, and tan colour means non-significantly spatial effect.
doi:10.1371/journal.pone.0035737.g008

early-stage breast cancer incidence also has been reported in other
studies [18,35], and we further illustrated its change over time in
Figure 1. Moreover, we also found a positive association of PCP
availability with breast cancer mortality over time. Although some
studies showed that higher PCP availability was associated with
lower mortality for some health conditions [36–38], we observed a
positive association, which might have been the result of
confounding by rurality, whereby counties considered to be more
urban had higher PCP availability and higher mortality (see
Figure 8). The time-varying socioeconomic deprivation was
significantly negatively associated with early-stage incidence from
1988 to 1990 in our study. Higher socioeconomic deprivation may
have led to lower screening mammography use resulting in lower
early-stage breast cancer rates [39]. Targeted efforts nationally to
increase screening among women living in areas with high
socioeconomic deprivation might very well account for the lack
of significant associations between socioeconomic deprivation and
early-stage incidence after 1990.
Our second finding showed large geographic disparities across
the SEER counties in the association of PCP availability and
socioeconomic deprivation with each breast cancer indicator; in
some counties there were positive associations and in other
counties there were negative associations. The geographic
disparity of PCP availability can be explained by Medicare
beneficiaries only residing in some counties with higher levels of
PLoS ONE | www.plosone.org

PCP availability, which have fewer preventable hospitalizations
and lower death rates [40]. The posterior probability of the
structured spatial effect in the VCM and REM identified specific
counties where significant associations between each of PCP
availability and socioeconomic deprivation and all three breast
cancer indicators were observed (Figures 2, 5 & 8). The positive
associations between each of PCP availability and socioeconomic
deprivation and the two early- and advanced-stage breast cancer
incidence indicators were significant for at least 20% of the 200
SEER counties, but the associations between each of PCP
availability and socioeconomic deprivation and breast cancer
mortality was significant for less than 20% of these SEER counties.
This finding suggests that the spatial function could identify more
significantly elevated incidence than mortality for breast cancer in
these 200 SEER counties. The observed significance of spatial
effects in the study areas confirms that spatial heterogeneity should
not be ignored, and was most pronounced in metropolitan SEER
areas. More importantly, these results can be used to target breast
cancer detection programs or prevention and control activities to
counties with elevated breast cancer incidence and mortality rates
and showed the importance of the local influence of PCP
availability and socioeconomic deprivation on breast cancer
indicators.
A major strength of our study was the sophistication of the
statistical modeling strategy. The STAR model goes beyond
9
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could be used in future investigation of spatio-temporal variations
in risk factors for other health conditions. In addition, the STAR
model takes into account data from neighboring counties, so our
results are less affected by small numbers than traditional
frequentist approaches.
Our study also included two limitations. First, our results may
be affected by scattered areas with a lack of neighboring counties
in metropolitan SEER areas, such as Atlanta, Detroit, Seattle, San
Francisco, and Connecticut. Ignoring these neighboring counties
that were not part of the SEER program data may have affected
the results of models. The influence of the neighboring counties on
counties near the outside boundary of each SEER area may have
been underestimated because those neighboring counties were
ignored. Second, the STAR model does not support the
implementation of space-time interaction, which resulted in our
inability to examine geographic variation over time, but this was
not a purpose of our study.
To sum up, this study showed important influences of PCP
availability and socioeconomic deprivation on three breast cancer
indicators in both temporal trends and geographic disparities. The
time-varying association of PCP availability was stronger than that
of socioeconomic deprivation. The SEER area-specific PCP
availability also displayed larger geographic disparities than
socioeconomic deprivation, especially in advanced-stage incidence
and mortality.
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